Stocks and Investing
Stocks and Investing
Tue, March 7, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Anupam Rama Maintained (SWTX) at Buy with Increased Target to $57 on, Mar 7th, 2023
Anupam Rama of JP Morgan, Maintained "SpringWorks Therapeutics, Inc." (SWTX) at Buy with Increased Target from $53 to $57 on, Mar 7th, 2023.
Anupam has made no other calls on SWTX in the last 4 months.
There are 2 other peers that have a rating on SWTX. Out of the 2 peers that are also analyzing SWTX, 0 agree with Anupam's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Anupam
- Corinne Jenkins of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $45 on, Thursday, January 26th, 2023
- Alec Stranahan of "B of A Securities" Initiated at Strong Buy and Held Target at $45 on, Thursday, December 1st, 2022
Contributing Sources